Christopher R. Lowe is Professor Emeritus of Biotechnology at the University of Cambridge and was founder Director of the Institute of Biotechnology at the University where he conducted multi-disciplinary research in both diagnostics and therapeutics in the healthcare biotechnology sector. He is a fellow of Trinity College, the Royal Academy of Engineering, the Institute of Physics and the Royal Society of Chemistry. He has 398 peer-reviewed publications, 8 books and monographs, >100 patents, has supervised >95 PhD students and has a number of national and international prizes: “Queen’s Award for Technological Achievement”; “Queen’s Anniversary Prize for Higher and Further Education”; “Most Entrepreneurial Scientist of the UK”; OBE in the Queen’s New Year Honours; BBSRC Commercial Innovator of the Year in 2011.
Besides being a member of a number of Editorial Boards, Funding Bodies and Government Committees, he has been the driving force for the establishment of 12 spin-out companies including ProMetic Biosciences Inc, Cambridge Sensors Ltd, Smart Holograms Ltd, Paramata Ltd, Psynova Neurotech Ltd, LabXero Ltd, TumourVue Ltd and Royale Therapeutics Ltd., has a number of directorships and fosters entrepreneurship within the University via a Master’s in Bioscience Enterprise, the University’s Seed Fund Committee (Cambridge Enterprise) and other Business School and student-led activities.
He is active in various overseas committees and in a number of legal and entrepreneurial roles. He is currently Director of the newly established Cambridge Academy of Therapeutic Sciences (CATS) within the University of Cambridge.